Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-060777

Options or other derivatives

  • Chief Financial Officer acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Brendan · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-10-14 Grant or award : show line 1 in the form Restricted Stock Units +15,000 15,000 D
2021-10-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +90,000 90,000 D
Loading xslF345X03/doc4.xml…